Founded in 2002 and listed on Shenzhen Chi‑Next Board with stock code 300633, SonoScape Medical Corp. is a listed national‑level high‑tech enterprise headquartered in Shenzhen.

We have established seven global R&D centers in Shenzhen, Shanghai, Wuhan of China, San Francisco, Seattle in USA, Tuttlingen in Germany and Tokyo in Japan with over 800 researchers and more than 900 authorized patents worldwide. We invest roughly 20% of annual revenue in R&D each year.

Our endoscopy portfolio includes self‑developed iEndo‑4K intelligent endoscopy platform, high‑definition flexible scopes, EBUS‑TBNA systems and 4‑K 3‑D fluorescence rigid‑endoscope camera systems approved by NMPA, CE‑MDR and FDA certifications. Our products serve gastroenterology, pulmonology, urology, gynecology, orthopedics and thoracic‑surgery departments. With branch offices across 30 major Chinese cities, our devices are exported to over 170 countries and territories globally. Committed to independent innovation and AI‑imaging technology, SonoScape delivers integrated endoscopy and minimally‑invasive‑surgery solutions for medical‑institutes worldwide.

Address: SonoScape Building, No.368 Guangguang North Road, Guangming District, Shenzhen, Guangdong Province, P.R.China.